Treatment of type 1 diabetes with anti-CD3 monoclonal antibody

被引：10
作者：
Glandt, M
Hagopian, W
Herold, KC
机构：
[1] Columbia Univ Coll Phys & Surg, Div Endocrinol, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Naomi Berrie Diabetes Ctr, New York, NY 10032 USA
[3] Pacific NW Res Inst, Seattle, WA USA
来源：
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS | 2003年 / 4卷 / 04期
关键词：
autoinimunity; immune therapy; type 1 diabetes mellitus; anti-CD3 monoclonal antibody;
D O I：
10.1023/A:1027354129493
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：361 / 368
页数：8
相关论文
共 48 条
[1]   Type 1 diabetes: new perspectives on disease pathogenesis and treatment [J].
Atkinson, MA ;
Eisenbarth, GS .
LANCET, 2001, 358 (9277) :221-229
[2]   TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes [J].
Belghith, M ;
Bluestone, JA ;
Barriot, S ;
Mégret, J ;
Bach, JF ;
Chatenoud, L .
NATURE MEDICINE, 2003, 9 (09) :1202-1208
[3]   T-CELL-MEDIATED INHIBITION OF THE TRANSFER OF AUTOIMMUNE DIABETES IN NOD MICE [J].
BOITARD, C ;
YASUNAMI, R ;
DARDENNE, M ;
BACH, JF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) :1669-1680
[4]   Autoantibody response to islet transplantation in type 1 diabetes [J].
Bosi, E ;
Braghi, S ;
Maffi, P ;
Scirpoli, M ;
Bertuzzi, F ;
Pozza, G ;
Secchi, A ;
Bonifacio, E .
DIABETES, 2001, 50 (11) :2464-2471
[5]   FACTORS ASSOCIATED WITH EARLY REMISSION OF TYPE-I DIABETES IN CHILDREN TREATED WITH CYCLOSPORINE [J].
BOUGNERES, PF ;
CAREL, JC ;
CASTANO, L ;
BOITARD, C ;
GARDIN, JP ;
LANDAIS, P ;
HORS, J ;
MIHATSCH, MJ ;
PAILLARD, M ;
CHAUSSAIN, JL ;
BACH, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (11) :663-670
[6]  
Chatenoud L, 1997, J IMMUNOL, V158, P2947
[7]   ANTI-CD3 ANTIBODY INDUCES LONG-TERM REMISSION OF OVERT AUTOIMMUNITY IN NONOBESE DIABETIC MICE [J].
CHATENOUD, L ;
THERVET, E ;
PRIMO, J ;
BACH, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) :123-127
[8]   INVIVO CELL ACTIVATION FOLLOWING OKT3 ADMINISTRATION - SYSTEMIC CYTOKINE RELEASE AND MODULATION BY CORTICOSTEROIDS [J].
CHATENOUD, L ;
FERRAN, C ;
LEGENDRE, C ;
THOUARD, I ;
MERITE, S ;
REUTER, A ;
GEVAERT, Y ;
KREIS, H ;
FRANCHIMONT, P ;
BACH, JF .
TRANSPLANTATION, 1990, 49 (04) :697-702
[9]  
CHATENOUD L, 1993, TRANSPLANT P, V25, P47
[10]  
Chatenoud L, 1993, Immunol Ser, V59, P175
12345